IFNG and neoplasm: EBI3 has revealed growth-promoting activity in lung cancer [60] and in colorectal cancer, by stimulating cell proliferation, via the gp130/STAT3 axis, and by restraining tumor infiltrating granzyme B+ CTLs and IFNγ+ CTLs [61], thus, allowing the cancer to escape immune surveillance.